Attached files

file filename
10-Q - FORM 10-Q - CAPRICOR THERAPEUTICS, INC.v347233_10q.htm
EXCEL - IDEA: XBRL DOCUMENT - CAPRICOR THERAPEUTICS, INC.Financial_Report.xls
EX-31.1 - EXHIBIT 31.1 - CAPRICOR THERAPEUTICS, INC.v347233_ex31-1.htm
EX-32.1 - EXHIBIT 32.1 - CAPRICOR THERAPEUTICS, INC.v347233_ex32-1.htm
EX-31.2 - EXHIBIT 31.2 - CAPRICOR THERAPEUTICS, INC.v347233_ex31-2.htm

 

EXHIBIT 32.2

 

CERTIFICATION OF CHIEF FINANCIAL OFFICER

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

Pursuant to 18 U.S.C. § 1350, as created by Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of Nile Therapeutics, Inc. (the “Company”) hereby certifies, to such officer’s knowledge, that:

 

(1) the accompanying Quarterly Report on Form 10-Q of the Company for the quarterly period ended September 30, 2012 (the “Report”) fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and

 

(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: June 21, 2013

 

/s/ Daron Evans
Name: Daron Evans
Title: Chief Financial Officer